Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Ivarmacitinib may effectively treat complex atopic dermatitis and related hair loss.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tofacitinib treatment is used for teenagers with alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Gefitinib can cause scalp skin issues and permanent hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Ruxolitinib helped a man regrow hair after other treatments failed.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.